Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-24-000462
Filing Date
2024-04-26
Accepted
2024-04-26 15:29:21
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10284
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 367205
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1785690
4 CPA AUDIT REPORT auditreport.pdf EX-99 465257
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 1044922
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 55960
7 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 157305
8 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-24-000462.txt   5351652
Mailing Address 982A N. BATAVIA STREET SUITE 10B ORANGE CA 92867
Business Address 982A N. BATAVIA STREET, SUITE 10B ORANGE CA 92867 5622098912
Rejuve Biotech Inc. (Filer) CIK: 0001994911 (see all company filings)

EIN.: 932218283 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-33659 | Film No.: 24882948